Artesunate acts through cytochrome c to inhibit growth of pediatric AML cells

Sci Rep. 2023 Dec 16;13(1):22383. doi: 10.1038/s41598-023-49928-y.

Abstract

Artesunate is a derivative of artemisinin, an active compound isolated from Artemisia annua which has been used in Traditional Chinese Medicine and to treat malaria worldwide. Artemisinin derivatives have exhibited anti-cancer activity against both solid tumors and leukemia. The direct target(s) of artesunate are controversial; although, heme-bound proteins in the mitochondria have been implicated. We utilized computational modeling to calculate the predicted binding score of artesunate with heme-bound mitochondrial proteins and identified cytochrome c as potential artesunate target. UV-visible spectroscopy showed changes in the absorbance spectrum, and thus protein structure, when cytochrome c was incubated with artesunate. Artesunate induces apoptosis, disrupts mitochondrial membrane potential, and is antagonized by methazolamide in pediatric AML cells indicating a probable mechanism of action involving cytochrome c. We utilized a multi-disciplinary approach to show that artesunate can interact with and is dependent on cytochrome c release to induce cell death in pediatric AML cell lines.

MeSH terms

  • Antimalarials* / pharmacology
  • Antimalarials* / therapeutic use
  • Artemisinins* / pharmacology
  • Artesunate / pharmacology
  • Child
  • Cytochromes c
  • Heme
  • Humans
  • Leukemia, Myeloid, Acute* / drug therapy

Substances

  • Artesunate
  • Antimalarials
  • Cytochromes c
  • Artemisinins
  • Heme